Cargando…
A Descriptive Review of Global Real World Evidence Efforts to Advance Drug Discovery and Clinical Development in Amyotrophic Lateral Sclerosis
Understanding patient clinical progression is a key gateway to planning effective clinical trials and ultimately enabling bringing treatments to patients in need. In a rare disease like amyotrophic lateral sclerosis (ALS), studies of disease natural history critically depend on collaboration between...
Autores principales: | Cook, Suzanne F., Rhodes, Thomas, Schlusser, Courtney, Han, Steve, Chen, Chao, Zach, Neta, Murthy, Venkatesha, Davé, Shreya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606522/ https://www.ncbi.nlm.nih.gov/pubmed/34819914 http://dx.doi.org/10.3389/fneur.2021.770001 |
Ejemplares similares
-
Qualitative measures that assess functional disability and quality of life in ALS
por: Hartmaier, Susan L., et al.
Publicado: (2022) -
Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019) -
Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021) -
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019) -
Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019)